Pak­istan Min­is­ter gives out reg­u­la­tory ad­vice to pharma in­dus­try

BioSpectrum (Asia) - - Regulatory News -

The Min­is­ter of State for Na­tional Health Ser­vices, Reg­u­la­tions and Co­or­di­na­tion stated that the lo­cal pharma in­dus­try is re­quired to ur­gently ad­dress the medicine reg­u­la­tory sys­tem for pa­tient safety. Min­is­ter Saira Afzal Tarar said this while pre­sid­ing over a phar­ma­ceu­ti­cal ex­port seminar at Islamabad. She said that for en­hanc­ing ex­ports, Drug Reg­u­la­tory Au­thor­ity Pak­istan (DRAP) and the lo­cal in­dus­try need to im­prove Good Man­u­fac­tur­ing Prac­tices (GMP) com­pli­ance.

Ma­jor­ity of lo­cal phar­ma­ceu­ti­cal com­pa­nies are still ex­port­ing to lease and low priced mar­ket, and are not able to en­ter into high priced mar­ket. The lo­cal in­dus­try needs to im­prove fa­cil­i­ties, ex­per­tise and prac­tices on one hand and at the same time they must per­form in­ten­sive mar­ket­ing cam­paigns to catch strin­gent and high-value mar­kets. For en­hanc­ing the ca­pac­ity of DRAP and the in­dus­try, the au­thor­ity in col­lab­o­ra­tion with in­ter­na­tional health part­ners has or­gan­ised a series of work­shops and train­ing sem­i­nars dur­ing last two years for cre­at­ing aware­ness and im­part­ing knowl­edge.

How­ever, the min­is­ter also stated that ma­jor re­forms in drug reg­u­la­tion in­tro­duced over the last three years have also led to an im­proved sit­u­a­tion with re­gards to ex­port of Pak­istani phar­ma­ceu­ti­cal prod­ucts.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.